Calendar PolyPeptide Group AG

Equities

PPGN

CH1110760852

Market Closed - Swiss Exchange 11:31:30 2024-04-26 am EDT 5-day change 1st Jan Change
29.55 CHF +2.43% Intraday chart for PolyPeptide Group AG +1.90% +68.66%

Chart calendar PolyPeptide Group AG

319bf41b6d04b3a4e60865c44440b.nPp1cV_SqCwrTAusjzlrjRlx1ANNTXCaRosIv0uyd3s.q6oeI2iawWVkIjv94nEk4E5c53QbBgjOd9RY_TjeLi3MoDweJpfnYV4eTg~8e3513caf90b6f4dcb554ee614a6009e

Upcoming events on PolyPeptide Group AG

2024-08-12 Q2 2024 Earnings Call
2024-08-12 Q2 2024 Earnings Release Pre-market
2025-03-10 Q4 2024 Earnings Call
2025-03-10 Q4 2024 Earnings Release
2025-04-08 Annual General Meeting
2025-08-11 Q2 2025 Earnings Call
2025-08-11 Q2 2025 Earnings Release
2026-03-16 Q4 2025 Earnings Release (Projected)
2026-08-17 Q2 2026 Earnings Release (Projected)
2027-03-15 Q4 2026 Earnings Release (Projected)
2027-08-16 Q2 2027 Earnings Release (Projected)

Past events on PolyPeptide Group AG

2024-04-10 10:00 am Annual General Meeting
2024-03-12 05:30 am Q4 2023 Earnings Call
2024-03-12 01:45 am Q4 2023 Earnings Release
2023-11-28 Nordic Life Science Days
2023-10-29 TIDES Europe Conference
2023-10-23 CPHI Conference
2023-10-15 Peptide Therapeutics Symposium
2023-09-17 Boulder Peptide Symposium
2023-09-16 Groupe Français des Peptides et Protéines Meeting
2023-09-05 RNA Leaders Congress
2023-08-15 03:30 am Q2 2023 Earnings Call
2023-08-15 01:00 am Q2 2023 Earnings Release
2023-07-13 03:30 am Q2 2023 Sales and Revenue Call
2023-07-13 01:00 am Q2 2023 Sales and Revenue Release
2023-04-23 Swiss Biotech Day
2023-04-13 American Association for Cancer Research Meeting
2023-04-12 10:00 am Annual General Meeting
2023-03-29 Biologics UK Conference
2023-03-19 BIO Europe Spring
2023-03-14 RNA Leaders Europe Congress

Past dividends on PolyPeptide Group AG

2022-04-27 0.3 CHF

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
223


282
276
2.13%
281
285
-1.41%
325
294
10.39%

349

EBITDA
Million EUR
Released
Forecast
Spread
0,00


84,8
89,4
-5.11%
38,7
43,1
-10.32%
-6,00
-5,57
-7.68%

26,2

EBIT
Million EUR
Released
Forecast
Spread
0,00


64,2
68,9
-6.8%
12,6
19,4
-34.87%
-36,5
-36,9
1.05%

-4,97

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
0,00


59,8
66,5
-10%
7,57
16,3
-53.67%
-58,2
-44,1
-32.22%

-12,6

Net income
Million EUR
Released
Forecast
Spread
31,3


47,3
54,6
-13.37%
7,77
13,3
-41.81%
-51,4
-36,6
-40.73%

-12,2

EPS
EUR
Released
Forecast
Spread
0,00


1,47
1,66
-11.66%
0,24
0,41
-41.1%
-1,56
-1,05
-48.99%

-0,30

Announcement Date15/03/2115/03/2214/03/2312/03/24-

Quarterly results

Fiscal PeriodDecember 2021 S1 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales
Million EUR
Released
Forecast
Spread
135


134
138
-3.26%
147
151
-2.69%
132
126
4.44%
191
167
14.37%

132


213

EBITDA
Million EUR
Released
Forecast
Spread
39,9


26,7
28,1
-4.99%



-19,4
-5,50
-252.49%
13,4
13,9
-3.74%

0,70


26,8

EBIT
Million EUR
Released
Forecast
Spread



15,5
15,5
-0.08%




-37,3

-2,00
-2,54
21.1%

-14,9


10,7

Net income
Million EUR
Released
Forecast
Spread



10,2
11,8
-13.16%
-2,48
1,90
-230.53%
-34,3
-44,9
23.68%




-19,8


8,70

EPS
EUR
Released
Forecast
Spread



0,31
0,36
-12.68%



-1,04
-1,36
23.53%









Announcement Date17/08/2118/08/2214/03/2315/08/2312/03/24--

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PPGN Stock
  4. Calendar PolyPeptide Group AG